TMCI Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. (TMCI) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: August 24, 2026 , by Treace John T. .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Treace John T. | Chief Executive Officer | Buy | 11,000 | $4.34 | $47.7K | 7,404,383 | |
| Treace John T. | Chief Executive Officer | Buy | 5,000 | $4.35 | $21.7K | 7,393,383 | |
| Treace John T. | Chief Executive Officer | Buy | 39,944 | $4.44 | $177.2K | 7,388,383 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.